Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Phathom Pharmaceuticals (Nasdaq: PHAT), a biopharmaceutical company specializing in gastrointestinal treatments, has announced its management team's participation in four major healthcare investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Phathom Pharmaceuticals (Nasdaq: PHAT), a biopharmaceutical company specializing in gastrointestinal treatments, has announced its management team's participation in four major healthcare investor conferences. The schedule includes Guggenheim's Inaugural Healthcare Innovation Conference in Boston (Nov 12), Stifel 2024 Healthcare Conference in New York (Nov 18), Jefferies London Healthcare Conference (Nov 20), and 7th Annual Evercore HealthCONx Conference in Coral Gables (Dec 3). Live webcasts will be available for most events, with recordings accessible for 90 days on the company's website.
Details
News Market Reaction – PHAT
The recorded move for PHAT in the trading session of this news was +3.67%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FLORHAM PARK, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following investor conferences in November and December:
Guggenheim’s Inaugural Healthcare Innovation Conference in Boston, MA
Date: Tuesday, November 12, 2024
Live Webcast: 9:30 am ET
Management to participate in one-on-one meetings throughout the conference
Stifel 2024 Healthcare Conference in New York, NY
Date: Monday, November 18, 2024
Live Webcast: 1:15 pm ET
Management to participate in one-on-one meetings throughout the conference
Jefferies London Healthcare Conference in London, UK
Date: Wednesday, November 20, 2024
Management to participate in one-on-one meetings throughout the conference
7th Annual Evercore HealthCONx Conference in Coral Gables, FL
Date: Tuesday, December 3, 2024
Live Webcast: 2:10 pm ET
Management to participate in one-on-one meetings throughout the conference
To access the live webcast and archived recordings of each event, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. Recordings will be available for 90 days following the conclusion of each meeting.
About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases. Phathom has in-licensed the exclusive rights to vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB) that is currently marketed in the United States as VOQUEZNA® (vonoprazan) tablets for the treatment of heartburn associated with Non-Erosive GERD in adults, the healing and maintenance of healing of Erosive GERD in adults and relief of associated heartburn, in addition to VOQUEZNA® TRIPLE PAK® (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA® DUAL PAK® (vonoprazan tablets, amoxicillin capsules) for the treatment of H. pylori infection in adults. For more information about Phathom, visit the company’s website at www.phathompharma.com and follow on LinkedIn and X.
MEDIA CONTACT
Nick Benedetto
1-877-742-8466
media@phathompharma.com
INVESTOR CONTACT
Eric Sciorilli
1-877-742-8466
ir@phathompharma.com
© 2024 Phathom Pharmaceuticals. All rights reserved. VOQUEZNA, VOQUEZNA DUAL PAK, VOQUEZNA TRIPLE PAK, Phathom Pharmaceuticals, and their respective logos are registered trademarks of Phathom Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.